These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 18183577)
1. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis. Gregory-Bass RC; Olatinwo M; Xu W; Matthews R; Stiles JK; Thomas K; Liu D; Tsang B; Thompson WE Int J Cancer; 2008 May; 122(9):1923-30. PubMed ID: 18183577 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Chowdhury I; Xu W; Stiles JK; Zeleznik A; Yao X; Matthews R; Thomas K; Thompson WE Endocrinology; 2007 Jan; 148(1):206-17. PubMed ID: 17038561 [TBL] [Abstract][Full Text] [Related]
3. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer]. Tang J; Cao L; Yi H; Tang C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375 [TBL] [Abstract][Full Text] [Related]
4. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers. Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Sasaki H; Sheng Y; Kotsuji F; Tsang BK Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757 [TBL] [Abstract][Full Text] [Related]
6. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma. Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297 [TBL] [Abstract][Full Text] [Related]
7. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line. Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754 [TBL] [Abstract][Full Text] [Related]
8. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Long Noncoding RNA E2F-Mediated Cell Proliferation Enhancing Long Noncoding RNA Is Involved in the Development of Chemoresistance of Cancer Cells to Carboplatin in Ovarian Endometrioid Adenocarcinoma. Zhao L; Yang J; Liu X; Fu X; Ding Y; Wang C Cancer Biother Radiopharm; 2019 Nov; 34(9):566-571. PubMed ID: 31621389 [No Abstract] [Full Text] [Related]
10. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line. Du P; Zhang X; Liu H; Chen L DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922 [TBL] [Abstract][Full Text] [Related]
11. HMGA2 gene is a promising target for ovarian cancer silencing therapy. Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175 [TBL] [Abstract][Full Text] [Related]
12. Bcl-XL and MCL-1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis. Brotin E; Meryet-Figuière M; Simonin K; Duval RE; Villedieu M; Leroy-Dudal J; Saison-Behmoaras E; Gauduchon P; Denoyelle C; Poulain L Int J Cancer; 2010 Feb; 126(4):885-95. PubMed ID: 19634140 [TBL] [Abstract][Full Text] [Related]
13. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Yan X; Fraser M; Qiu Q; Tsang BK Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436 [TBL] [Abstract][Full Text] [Related]
14. Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways. Wu PP; Chung HW; Liu KC; Wu RS; Yang JS; Tang NY; Lo C; Hsia TC; Yu CC; Chueh FS; Lin SS; Chung JG Int J Oncol; 2011 Jun; 38(6):1605-13. PubMed ID: 21424116 [TBL] [Abstract][Full Text] [Related]
15. Prohibitin 1 inhibits cell proliferation and induces apoptosis Shi JJ; Wang YK; Wang MQ; Deng J; Gao N; Li M; Li YP; Zhang X; Jia XL; Liu XT; Dang SS; Wang WJ World J Gastrointest Oncol; 2024 Feb; 16(2):398-413. PubMed ID: 38425403 [TBL] [Abstract][Full Text] [Related]
16. [Study on RNA interference silencing hMSH2 induces the reversal chemo-resistance of ovarian carcinoma cell line OC3/TAX300]. Wang A; Li J; Li H Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):213-7. PubMed ID: 24820308 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1. Cirilo PDR; de Sousa Andrade LN; Corrêa BRS; Qiao M; Furuya TK; Chammas R; Penalva LOF BMC Cancer; 2017 Nov; 17(1):750. PubMed ID: 29126391 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
19. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma. Liu X; Wang A; Gao H; Yuan Z; Jiao Y Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624 [TBL] [Abstract][Full Text] [Related]
20. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]